Impact of adrenalectomy on 5-HT6 and 5-HT7 receptor gene expression in the rat hippocampus

Molecular Brain Research

Volumn 45, Issue 1, 1997, Pages 182-186

  Yau, Joyce L W ^a,b   Noble, June ^a   Widdowson, Judith ^a   Seckl, Jonathan R ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Aminoglutethimide; Gene expression; Glucocorticoid; Hippocampus; Metyrapone; Serotonin receptor

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN 1 RECEPTOR;

ADRENALECTOMY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEPRESSION; GENE EXPRESSION; HIPPOCAMPUS; NONHUMAN; PRIORITY JOURNAL; RAT;

ADRENALECTOMY; ANIMALS; ANTISENSE ELEMENTS (GENETICS); CORTICOSTERONE; DENTATE GYRUS; DNA PROBES; HIPPOCAMPUS; MALE; PYRAMIDAL CELLS; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0031128218     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(97)00026-0     Document Type: Article

References (28)

1. [1] Birnstiel, S. and Beck, S.G., Modulation of the 5-hydroxytryptamine-4 receptor-mediated response by short-term and long-term administration of corticosterone in rat CA1 hippocampal pyramidal neurons, J. Pharmacol. Exp. Ther., 273 (1995) 1132-1138.
2. [2] Brady, L.S., Gold, P.W., Herkenham, M., Lynn, A.B. and Whitfield Jr., H.J., The antidepressants fluoxetine, idazoxan and pnenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications, Brain Res., 572 (1992) 117-125.
3. [3] Brady, L.S., Whitfield Jr., H.J., Fox, R.J., Gold, P.W. and Herkenham, M., Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase and mineralocorticoid receptor gene expression in the rat brain, J. Clin. Invest., 87 (1991) 831-837.
4. 1A receptor mRNA expression, J. Neurosci., 13 (1993) 914-923.
5. [5] Chaouloff, F., Physiopharmacological interactions between stress hormones and central serotonergic systems, Brain Res. Rev., 18 (1993) 1-32.
6. [6] Chaouloff, F., Regulation of 5-HT receptors by corticosteroids: where do we stand? Fund. Clin. Pharmacol., 9 (1995) 219-233.
7. [7] De Kloet, E.R., Sybesma, H. and Reul, J.M.H.M., Selective control by corticosterone of serotonin I receptor capacity in raphe hippocampal system, Neuroendocrinology, 42 (1986) 513-521.
8. [8] Dinan, T., Monoamines and steroids: a unifying hypothesis of mood disorder, J. Serotonin Res., 1 (1995) 233-242.
9. 7 receptor in rat brain, Br. J. Pharmacol., 117 (1996) 657-666.
10. [10] Holmes, M.C., Yau, J.L.W., French, K.L. and Seckl, J.R., The effect of adrenalectomy on 5-HT and corticosteroid receptor subtype mRNA expression in rat anterior hippocampus and dorsal raphe nucleus, Neuroscience, 64 (1995) 327-337.
11. [11] Kramlinger, K.G., Peterson, G.C., Watson, P.K. and Lazaro, L.L., Metyrapone for depression and delirium secondary to Cushing's syndrome, Psychosomatics, 26 (1985) 67-71.
12. 7) implicated in the regulation of mammalian circadian rhythms, Neuron, 11 (1993) 449-458.
13. [13] Lucas, J.J. and Hen, R., New players in the 5-HT receptor field: genes and knockouts, Trends Pharmacol. Sci., 16 (1995) 246-252.
14. [14] Meijer, O.C. and De Kloet, E.R., Corticosterone suppresses the expression of 5-HT1a receptor mRNA in the rat dentate gyrus, Eur. J. Pharmacol., 266 (1994) 255-261.
15. 1b receptors in the dorsal hippocampus and cortex of the rat, Neuroendocrinology, 55 (1992) 444-450.
16. [16] Mitchell, J.B., Rowe, W., Boksa, P. and Meaney, M., Serotonin regulates type II corticosteroid receptor binding in hippocampal cell cultures, J. Neurosci., 10 (1990) 1745-1752.
17. [17] Monsma, F.J.J., Shen, Y., Ward, R.P., Hamblin, M.W. and Sibley, D.R., Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs, Mol. Pharmacol., 43 (1993) 320-327.
18. [18] Murphy, B., Dhar, V., Chadirian, A., Chouinard, G. and Keller, R., Response to steroid suppression in major depression resistant to antidepressant therapy, J. Clin. Psychopharmacol., 2 (1991) 121-126.
19. [19] Plotsky, P.M. and Sawchenko, P.E., Hypophysial-portal plasma levels, median eminence content and immunostaining of corticotropin-releasing factor, arginine vasopressin and oxytocin after pharmacological adrenalectomy, Endocrinolology, 120 (1987) 1361-1369.
20. [20] Reul, J.M.H.M., Stec. I., Söder, M. and Holsboer, F., Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system, Endocrinology, 133 (1993) 312-320.
21. 6) receptor: molecular cloning, localisation and stimulation of cAMP accumulation, Biochem. Biophys. Res. Commun., 193 (1993) 268-276.
22. [22] Seckl, J.R., Dickson, K.L. and Fink, G., Central 5,7-dihydroxytryptamine lesions decrease hippocampal glucocorticoid and mineralocorticoid receptor messenger ribonucleic acid expression, J. Neuroendocrin., 2 (1990) 911-916.
23. [23] Seckl, J.R. and Fink, G., Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in the rat hippocampus in vivo, Neuroendocrinology, 55 (1992) 621-626.
24. 7 serotonin receptor subtype, J. Biol. Chem., 268 (1993) 18200-18204.
25. [25] Ward, R.P., Hamblin, M.W., Lachowicz, J.E., Hoffman, B.J., Sibley, D.R. and Dorsa, D.M., Localization of serotonin subtype 6 receptor messenger RNA in the rat brain by in situ hybridization histochemistry, Neuroscience, 64 (1995) 1105-1111.
26. 1C receptor gene expression in the rat hippocampus. Neuroscience. 61 (1994) 31-40.
27. [27] Yau, J.L.W., Olsson, T., Morris, R.G.M., Meaney, M.J. and Seckl, J.R., Glucocorticoids, hippocampal corticosteroid receptor gene expression and antidepressant treatment: relationship with spatial learning in young and aged rats, Neuroscience, 66 (1995) 571-581.
28. 1a receptors by corticosteroid hormones, Mol. Brain Res., 29 (1995) 23-24.